NCT04432792

Brief Summary

This study aims to assess efficacy and safety outcomes of a telehealth model of abortion care. The study will compare efficacy of this model to usual in-clinic care based on published rates. It will also investigate participant acceptability and feasibility of this model of care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6,020

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 16, 2020

Completed
11 months until next milestone

Study Start

First participant enrolled

May 1, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
Last Updated

February 3, 2023

Status Verified

February 1, 2023

Enrollment Period

1.2 years

First QC Date

June 11, 2020

Last Update Submit

February 1, 2023

Conditions

Keywords

TelemedicineTelehealthTelephoneRemote

Outcome Measures

Primary Outcomes (4)

  • The proportion of participants with a successful abortion

    The proportion of participants who have a successful abortion defined as complete abortion without continuing pregnancy, need for manual vacuum aspiration or an additional round of treatment to complete the abortion.

    Documented resolution of pregnancy, for most patients assessed at 7 days

  • The proportion of participants reporting satisfaction with telehealth for abortion

    The proportion of participants reporting being satisfied or very satisfied with telehealth for abortion.

    Documented satisfaction measured at approximately 4 weeks follow up

  • The proportion of participants reporting they would use the telehealth option again if needed

    The proportion of participants reporting they would use the telehealth option again if needed

    Documented at approximately 4 weeks follow up

  • The total percentage of participants who carried out the study tasks as directed.

    The total percentage of participants who carried out the study tasks as directed.

    Documented at the 7 day follow up survey

Secondary Outcomes (1)

  • The total percentage of participants who experienced a major adverse event

    Assessed at the 7 day and 4 week follow up surveys or any unscheduled contacts from participants

Study Arms (2)

Clinical Records Review

We will receive clinical chart data from the telehealth providers on 3,000 patients (which could include the survey study participants, but we will not know their identities) which will include date of birth, zip code, and dates of service - but will otherwise be de-identified.

Study Survey Participants

We aim to enroll at least 3,000 participants to complete the study surveys.

Other: Questionnaire

Interventions

Study survey participants will be administered 3 online surveys.

Study Survey Participants

Eligibility Criteria

Age13 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsAny pregnant person seeking medication abortion regardless of gender identity.
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study will aim to reach a diverse sample of medication abortion patients across the country in states where care is provided including California, New York, and Washington, thus far. In California alone, an estimated 50% of all abortions are medication abortions resulting in \>66,000 medication abortions per year. California accounts for 20% of the nation's medication abortions.

You may qualify if:

  • Current patient of a participating telehealth platform for medication abortion (includes ages 13-64 years)
  • Able to read and write in English or Spanish
  • Willing to participate in enrollment survey and two follow-up surveys

You may not qualify if:

  • Not a current patient of a participating telehealth platform for medication abortion
  • Unable to read or write in English or Spanish
  • Unwilling to participate in study surveys

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Advancing New Standards in Reproductive Health (ANSIRH)

San Francisco, California, 94612, United States

Location

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Ushma Upadhyay, PhD, MPH

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2020

First Posted

June 16, 2020

Study Start

May 1, 2021

Primary Completion

June 30, 2022

Study Completion

June 30, 2022

Last Updated

February 3, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations